Community‐Acquired Pneumonia

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|34|3|212-217

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.34, Iss.3, 2004-09, pp. : 212-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tigecycline: In Community-Acquired Pneumonia

By McKeage Kate   Keating Gillian M.  

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2633-2644

Adis International

Access to resources Recommend Favorite

Management of Community-Acquired Pneumonia in Children

By Chetty Krishne   Thomson Anne H.  

Pediatric Drugs, Vol. 9, Iss. 6, 2007-01 ,pp. : 401-411

Adis International

Access to resources Recommend Favorite

Current treatment of community-acquired pneumonia

By Liapikou Adamantia  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1319-1332

Informa Healthcare

Access to resources Recommend Favorite

Therapies in development for community-acquired pneumonia

By Tarsia Paolo   Blasi Francesco   Cazzola Mario   Cosentini Roberto   Braga Piercarlo  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Infliximab/methotrexate: Community-acquired pneumonia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite